- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource, 1 online resource.
- Language
-
Englisch
- Bibliographic citation
-
Correction to: Relugolix: A Review in Advanced Prostate Cancer ; volume:18 ; number:4 ; day:18 ; month:5 ; year:2023 ; pages:637 ; date:7.2023
Targeted oncology ; 18, Heft 4 (18.5.2023), 637, 7.2023
- Creator
-
Shirley, Matt
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s11523-023-00977-3
- URN
-
urn:nbn:de:101:1-2023101809214556270610
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:55 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Shirley, Matt
- SpringerLink (Online service)
Other Objects (12)
Hormonal treatment of advanced prostate cancer
Correction to: Darolutamide: A Review in Metastatic Hormone-Sensitive Prostate Cancer
Treatment of locally advanced prostate cancer: a case report and narrative review
Correction to: Durvalumab: A Review in Advanced Biliary Tract Cancer
Correction: The CDK7 inhibitor CT7001 (Samuraciclib) targets proliferation pathways to inhibit advanced prostate cancer
Correction to: Darolutamide: A Review in Non-Metastatic Castration-Resistant Prostate Cancer
Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015
Pilot Study: PARP1 Imaging in Advanced Prostate Cancer
The association between metabolic syndrome and the risk of prostate cancer, high-grade prostate cancer, advanced prostate cancer, prostate cancer-specific mortality and biochemical recurrence
The role of cystoprostatectomy in management of locally advanced prostate cancer: a systematic review
Co‐Targeting Plk1 and DNMT3a in Advanced Prostate Cancer
Co‐Targeting Plk1 and DNMT3a in Advanced Prostate Cancer
Hormonal treatment of advanced prostate cancer
Correction to: Darolutamide: A Review in Metastatic Hormone-Sensitive Prostate Cancer
Treatment of locally advanced prostate cancer: a case report and narrative review
Correction to: Durvalumab: A Review in Advanced Biliary Tract Cancer
Correction: The CDK7 inhibitor CT7001 (Samuraciclib) targets proliferation pathways to inhibit advanced prostate cancer
Correction to: Darolutamide: A Review in Non-Metastatic Castration-Resistant Prostate Cancer
Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015
Pilot Study: PARP1 Imaging in Advanced Prostate Cancer
The association between metabolic syndrome and the risk of prostate cancer, high-grade prostate cancer, advanced prostate cancer, prostate cancer-specific mortality and biochemical recurrence
The role of cystoprostatectomy in management of locally advanced prostate cancer: a systematic review
Co‐Targeting Plk1 and DNMT3a in Advanced Prostate Cancer
Co‐Targeting Plk1 and DNMT3a in Advanced Prostate Cancer
Hormonal treatment of advanced prostate cancer
Correction to: Darolutamide: A Review in Metastatic Hormone-Sensitive Prostate Cancer
Treatment of locally advanced prostate cancer: a case report and narrative review
Correction to: Durvalumab: A Review in Advanced Biliary Tract Cancer
Correction: The CDK7 inhibitor CT7001 (Samuraciclib) targets proliferation pathways to inhibit advanced prostate cancer
Correction to: Darolutamide: A Review in Non-Metastatic Castration-Resistant Prostate Cancer
Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015
Pilot Study: PARP1 Imaging in Advanced Prostate Cancer
The association between metabolic syndrome and the risk of prostate cancer, high-grade prostate cancer, advanced prostate cancer, prostate cancer-specific mortality and biochemical recurrence
The role of cystoprostatectomy in management of locally advanced prostate cancer: a systematic review
Co‐Targeting Plk1 and DNMT3a in Advanced Prostate Cancer